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ABSTRACT 
Back ground: Urinary kidney injury molecule 1 (KIM-1) is early biomarker for renal damage. A few 
studies have been published analyzing the potential use of urinary kidney injury molecule-1 (KIM-1) as a 
biomarker for acute kidney injury. However no study has been done related to Acute Kidney Injury associated 
with contrast administration. 
Aim: To search for new markers to identify Acute Kidney Injury (ARF) associated with contrast administration 
earlier than serum creatinine. 
Material and Methods: We studied 100 consecutive patients with normal serum creatinine undergoing 
angiographic procedure. We assessed urine KIM-1, at 4h, 8h, and 24 hours after the angiographic procedure. 
Serum creatinine was measured at basal, 24h and 48 hours after the procedure.  
Results: There was a significant rise in urinary KIM-1 levels at 24 hours after the angiographic procedure. The 
presence of contrast induced nephropathy associated with acute Kidney Injury was 12%. 
Conclusion: The present study highlighted the importance of urinary KIM-1 in detecting Acute Kidney Injury 
associated with contrast administration earlier than Serum creatinine.  
Key words: Neutrophil-gelatinase-associated lipocalin. Contrast-induced nephropathy. Cystatin C. Glomerular 
Filtration Rate (GFR), Kidney injury molecule -1 (KIM-1). 
INTRODUCTION 
The requirement for radiological investigations using contrast media has increased. Contrast induced 
nephropathy is emerging a significant source of hospital morbidity and mortality with the ever increasing use of 
iodinated contrast media in diagnostic imaging and interventional procedures such as angiography. The rate of 
incidence of contrast-induced nephropathy as a complication of radiographic diagnostic and interventional 
studies varies markedly, depending on the definition used and on other variables such as the type of radiology 
procedure performed, the dose and type of contrast agent administered, the differing patient populations in 
regard to number and type of risk factors, and the length of patient follow-up renal function deterioration 
according to most authors is referred to an increase of serum creatinine concentration of >0.5 mg/dl or 25% 
above baseline, within 48 hours after contrast medium administration. Contrast induced nephropathy is most 
commonly defined as Acute Kidney Injury occurring within 48 hours of exposure to intravascular radiographic 
contrast material that is not attributable to other causes1. Contrast induced acute kidney injury (CIAKI) has 
subsequently become the third most common reason for the development of in-hospital acute kidney injury 
accounting for 12% of cases2. This iatrogenic complication has been a subject of concern in recent years because 
of its adverse effects on prognosis and addition to health care costs. The exact underlying mechanisms of 
nephrotoxicity have yet to be fully elucidated but are likely to involve the interplay of several pathogenic factors. 
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Several studies revealed that contrast medium can cause kidney damage and even cell death. Moreover, contrast 
medium can reduce blood flow through kidney areas that are risk for hypoxic damage and tubular fluid flow is 
similarly affected. Traditional biomarkers of renal injury, including serum creatinine and blood urea have lacked 
the sensitivity and / or specificity to adequately detect nephrotoxicity prior to significant loss of renal function. 
The absence of sensitive and specific biomarkers for the early detection of acute kidney injury (AKI) has 
impaired progress in the diagnosis and treatment of patients with AKI. Therefore, there is a need to identify a 
more specific AKI biomarker that is produced at the site of injury and that can be measured easily in blood or 
urine and should be reasonably stable in body fluid to substantially improve the diagnosis.  
Kidney Injury molecule -1 (KIM-1) as a type I membrane glycoprotein, which contain a 6- cystein 
immunoglobulin-like domain in its extracellular portion, and a Thr/Ser-Pro rich doain characteristic of mucin –
like O-glycosylated proteins3. KIM-1 presence in the urine is highly specific for kidney injury. No other organs 
have been shown to express KIM-1 to a degree that would influence kidney excretion. Kidney Injury molecule -
1 (KIM-1) expression is induced in a variety of renal diseases, whereas in healthy kidney tissue KIM-1 is 
virtually undetectable3-4 . In the case of kidney damage, KIM-1 is expressed on the apical membrane followed by 
cleavage of the ectodomain (90 kDa) which is released in the urine in humans5-6. 
 KIM-1 is upregulated in the proximal tubule during dedifferentiation of the kidney epithelium, an early 
manifestation in response to damage7. There is no studies to date that have examined KIM-1 for detection of 
AKI associated with contrast administration. There is an urgent need for improved and non-invasive renal 
biomarkers to permit early detection of AKI associated with contrast induced nephropathy. Kidney injury 
molecule (KIM-1) a transmembrane tubular protein, is undetectable in normal kidneys, but it is markedly 
induced in renal injury including acute kidney injury (AKI) and chronic kidney disease (CKD) 7-9. Many studies 
indicate that KIM-1 is a sensitive and specific marker of kidney injury as well as a predictor of prognosis10-11. 
The above characteristics make KIM-1 an ideal marker for Acute Kidney injury (AKI). The objective of the 
present study was to examine the ability of KIM-1 in detecting contrast induced acute kidney injury. We 
assessed urinary KIM-1 values in relation to serum creatinine in these patients. 
Table1: Basal clinical characteristics of patients undergoing angiography. 
Parameter  Value 
Age in years 48.6 ±11.0 
Systolic BP, mmHg 136.5±29.0 
Diastolic BP, mmHg 80.5±20.0 
Heamoglobin, g/dl 14.5±2.0 
HbA1c % 5.0±2.5 
Serum creatinine, mg/dl 1.2±0.17 
eGFR byMDRD equation, ml/min 81.2±22.0 
Cholesterol, mg/dl 168±43 
HDL, mg/dl 44±10 
Fasting Blood Sugar, mg/dl 115±41 
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MATERIALS AND METHODS 
The study was performed in one hundred consecutive patients undergoing angiographic procedure. The study 
was approved by the Ethics Committee of Micropath Medical Center, Gurgaon, Haryana.  Written informed 
consent was obtained from each patient before enrolment. All consecutive adult patients undergoing coronary 
angiographic procedure from January, 2012 to April, 2013 were included. Clinical characteristics of all patients 
from whom urine was evaluated for KIM-1 are reported in Table No.1. Patients with diabetic mellitus comprised 
38 of 21 male and 17 females. Patients with non-diabetic mellitus comprised 62 of 41 male and 21 females. 
Among diabetic patients, 14 were treated with insulin and the rest with oral hypoglycemic drugs. 
 All subjects were discharged home from the angiography area after 8 hours of their procedure with advice to 
give specimen at scheduled time and encouraged to drink about 1.5 liters of water at least for the first 24 hours. 
The coronary angiography was performed by a consultant doctor in a standard manner using femoral artery. We 
excluded patients with pre-existing chronic kidney disease, serum creatinine greater than 1.5 mg/dl in males and 
1.3 mg/dl in females. None of the subjects investigated had received nephrotoxic drugs at least 2 weeks before 
and during the study period.  Before the procedure, all of the participating patients were given their urine and 
blood specimens for investigations such as cholesterol, High Density Lipoprotein, (HDL), Triglycerides, 
Hemoglobin, HbA1C and Fasting Blood Sugar (FBS). Blood pressure (BP) also studied on admission. Each 
patient was given low-osmolar contrast (iodizanol or iopromide) medium. Specific protocols and medications for 
contrast induced nephropathy prevention were not used in this study, but patients were persistently encouraged 
to drink plenty of fluids and oral fluid intake was maximally encouraged.  
Blood samples were collected for serum creatinine and other screening evaluation before (at basal level). 
Thereafter urine samples were collected at 4 hours, 8 hours, 12 hours and 24 hours after the angiographic 
procedure. Urinary Samples were kept for 30 minutes at room temperature then supernatant was stored at -80 
deg C. Serum creatinine was assessed before ( at basal level), and 24h and 48 hours after the procedure using 
Jaffe method.  Kidney Injury molecule (KIM-1) was evaluated using a commercially available enzyme-linked 
immunosorbent assay (USCN Life Science Inc, Wuhan 430056, P.R.China).  KIM-1 test was performed 
according to manufactures instruction. For the choice of optimal cut-off, receiver operating characteristic (ROC) 
curve were constructed and the Youden index was calculated12. The Youden index is defined as follows: 
(sensitivity+specificity)-1. The best cut-off is the highest Youden index. The commercial statistical software 
package SPSS17.0 (SPSS, Inc, Chicago, IL, USA) was utilized. Results are evaluated with 95% confidence 
intervals. The significance level was< 0.05. 
RESULTS 
Clinical and biochemical characteristics of patients with normal serum creatinine values undergoing 
angiographic procedure are presented in Table 1. We found a significant rise in urinary KIM-1 at 24 h after the 
angiographic procedure. eGFR did not change significantly during 48 hours. When acute kidney injury was 
defined as an increase in serum creatinine by >25% of the baseline level 48 hours after contrast exposure, the 
prevalence of Acute Kidney Injury was 12%. The patients with AKI did not significantly differ with regard to 
age, blood pressure, serum creatinine, serum lipid levels before angiography when compared to patients without 
AKI. The serum creatinine levels 48 h after the angiography were significantly higher in the patients with AKI 
than in those without AKI (1.39±0.27vs1.12±0.17 mg/dl, p<0.001). 
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Fig.1: Receiver operative characteristics (ROC) showing curve against serum creatinine 48 hrs vs 24h urinary 
kim-1 and Contrast induced Acute Kidney Injury, defined as a serum creatinine increase by >25% of the baseline 
level 48 hours  after angiographic procedure.. Using a cutoff value of 4.5 ng/ml, sensitivity, specificity and area 
under the receiver operating characteristic (ROC) curve for prediction of Acute Kidney Injury was very good 
urinary kim-1 at 24 hours (89%, 81% and 0.95 respectively).   
 
The eGFR by MDRD formula 48 h after the angiography was significantly lower in the patients with AKI than 
in those without (63.45±18.64 vs 82.95±24.35 ml/min, p<0.05). The AKI was diagnosed in 12 patients at 24 
hours following angiographic procedure.  No significant differences were noted between patients with and 
without AKI in respect of age, sex , DM and Non-DM. (Table No.2).  Urinary KIM-1 values were higher at 24h  
after the angiographic procedure. There was a mild increase in serum creatinine at 24h and milder at 48 hours 
after the angiographic procedure, but there was no significant increase in eGFR during 48 hours of the 
procedure.  
We used AKI definition as rise in serum creatinine by >25%  over baseline, 48 hours after angiographic 
procedure. Patients after angiographic procedure are typically discharged within 48 hours sometimes even 
earlier, therefore, we could miss patients with AKI developing 48 hours after angiography. 24 hours after 
angiography, compared with the non-CIN group, urinary KIM-1 (ng/ml) levels of AKI group increased 
significantly 5.32 (4.64, 5.74) vs 4.24 (3.91, 4.61), P<0.05, the urinary KIM-1(ng/ml)  levels were significantly 
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increased 5.32 ((4.64, 5.74) vs 3.31(2.73, 4.28), P<0.05, from levels of 4 hours to 24 hours after contrast 
administration  in the AKI group.  
Table: 2 Time course changes in serum creatinine and urinary KIM-1, eGFR and blood pressure (BP) in patients 
undergoing angiography. 
Name of the 
parameter 
Before 
angiography 
After 2 hrs After 4 hrs After 8 hrs After 24 hrs After 48 hrs 
Urinary KIM-1, ng/ml ND ND 3.1(2.54-
4.16) 
4.1(2.66-
4..87) 
5.31(4.53-
5.74) 
ND 
Serum Creatinine, 
mg/dl 
1.2±0.17 ND ND ND 1.21±0.26 1.32±0.27 
eGFR by MDRD 
equation, ml/min 
81.11±25.30 ND ND ND 77.8±25.32 80.13±24.38 
Cystolic BP, mmHg 135.45±30.5 127.5±30.5 ND ND 136.45±25.65 135.75±25.25 
Diastolic BP, mmHg 81.5±23.5 80.5±21.5 ND ND 81.5±16.4 81.65±13.55 
 
ND: Not determined. Data given are mean values ± SD or median values (minimum-maximum).  
Using the Youden index, the best cutoff value for urinary KIM-1 at 24 hours to predict acute Kidney Injury was: 
4.5 ng/ml, with diagnostic sensitivity 89% and specificity 81%. 
DISCUSSION 
The traditional laboratory approach for detection of  renal disease does not allow for early detection of acute 
renal injury. Damage to renal tubules can be insufficient to result in a change in a parameter of kidney function 
such as blood urea and serum creatinine. In addition, in cases of more extensive tubular injury, there is a lag in 
time between the injury and an increase in serum creatinine. RIFLE and AKIN Criteria: In 2002, the Acute 
Dialysis Quality Initiatives (ADQI) group proposed a standard definition and classification system for the 
syndrome of acute renal failure through a broad consus of experts across disciplines and international 
boundaries. The classification systems coins the acronym RIFLE and has three levels: risk, injury and failure; 
and two outcomes: persistent acute renal failure (termed loss) and End stage Kidney disease. A unique feature of 
the RIFLE classification is that it provides retrospectively for three grades of severity of renal dysfunction on the 
basis of a maximum change in serum creatinine, reflecting changes in GFR or duration and severity of decline in 
urine output from the baseline. Based on the findings that small alterations of serum creatinine result in adverse 
outcomes, the Acute Kidney Injury International collaborative Network (AKIN) recently changed the definition 
of Risk group to include patients with an increase in serum creatinine of 0.3 mg/dl13. The proposed diagnostic 
and staging criteria for AKI are designed to facilitate acquisition of knowledge and to validate the emerging 
concepts. Serum creatinine is the most widely used parameter for everyday assessment of glomerular filtration 
rate (GFR), but it has poor sensitivity and specificity in ARF because serum creatinine lags behind both renal 
injury and renal recovery13.  Therefore, sensitive biomarkers of renal tubular injury are needed to detect early 
kidney injury. 
About a decade ago, KIM-1 was discovered in the search for molecule involved in the pathogenesis of acute 
kidney injury. Ichimura et al. were the first to describe KIM-1 as a type I membrane glycoprotein, which contain 
a 6- cystein immunoglobulin-like domain in its extracellular portion, and a Thr/Ser-Pro rich domain 
characteristic of mucin –like O-glycosylated proteins3. KIM-1 presence in the urine is highly specific for kidney 
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injury. No other organs have been shown to express KIM-1 to a degree that would influence kidney excretion. In 
the study of nephrotoxicity, urinary KIM-1 levels increased severely earlier than the increase of blood urea 
nitrogen and plasma creatinine7. KIM-1 is also a tissue and urinary biomarker for nephrotoxicant-induced kidney 
injury. Tissue and urinary expressions were measured with different nephrotoxic doses of cisplatin, folic acids, 
cadmium, gentamycin, mercury and chromium14-16.  In fact the Food and Drug Administration (FDA) and the 
European Medicines Evaluation Agency (EMEA) have included KIM-1 in the small list of kidney injury 
biomarkers that they will now consider in the evaluation of kidney damage as part  of their respective drug 
review processes of new drugs. FDA News. FDA, European medicines agency to consider additional test results 
when assessing new drug safety collaborative effort by FDA and EMEA expected to yield additional safety 
data17.  Therefore new promising markers were investigated to find the ways to diagnose Acute Kidney Injury at 
the earliest possible time. Serum creatinine levels began to rise within 24 hours in 80% of the patients, reaching 
maximum at 48-72 hours after contrast administration, returning to baseline after 2 weeks13. 
 
 In our present study, the prevalence of AKI due to contrast administration was 12 %. The reported incidence of 
AKI due to contrast induced nephropathy varies widely, ranging from 0 to >50%18. This variability results from 
whether presence or absence of risk factors (primarily renal sufficiency), the definition of CIN, amount and type 
of contrast agent administered, the exact radiologic procedure and whether other causes of Acute Kidney Injury 
(AKI) unrelated to contrast media were excluded. There have been over 16 definitions used for the diagnosis of 
acute renal failure in previously published studies, with most of them based on serum creatinine values. Recently 
the Acute Kidney injury Network has supported the use of the term ‘acute kidney injury’ to reflect the broad 
spectrum of acute kidney disease, including conditions that do not progress to failure19.  
In a study conducted by WK Han, et al revealed that the Urinary KIM-1 increased at 6-12 h after cardio-
pulmonary bypass surgery (CPB) and remained significantly elevated upto 48 hours after CPB. In their study 
urinary KIM-1 had an AUC-ROC of 0.57 at 2h, 0.83 at 12 h, and 0.78 at 24 h20.  Nejat M et al found in a study 
that the Kidney injury molecule-1 (KIM-1) is elevated in pre-renal azotemia to a lesser extent than in more 
severe AKI (lasting more than 48 hours) 21. Therefore, the heterogeneity of AKI suggests that more than one 
marker may be necessary to obtain sufficient sensitivity and specificity for AKI screening. Analysis of multiple 
biomarkers such as NGAL, Cystatin C with KIM-1 may optimize early detection of AKI associated with contrast 
administration at the earliest.  
CONCLUSION:  
 Kidney injury molecule-1 is an epithelial cell adhesion molecule that is induced in damaged tubular epithelial 
cells undergoing dedifferentiation and proliferation and the role of KIM-1 as a biomarker has a roubust future. 
The present study revealed that the  urine KIM-1 at 24 hours after angiographic procedure can detect acute 
Kidney Injury associated with contrast administration earlier than serum creatinine. Limitation of this study is 
that we could not include L-FABP  which is a new marker for acute Kidney Injury and We could have missed 
patients who developed acute Kidney Injury after 48 hours of the procedure. In summary, this is the first study to 
test the efficiency of new bio-markers in this setup revealing advantages of urinary KIM-1. The population 
studied is not representative of the global group of patients with AKI associated with Contrast administration. 
Our findings may have important implications for the clinical management of patients undergoing angiographic 
procedure. Further studies in patients undergoing radio-contrast administration are required to assess the 
usefulness of KIM-1 as a biomarker for early diagnosis. 
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